Treatment of chronic cough with sputum according to harrison textbook
Reading File
Finding Sources
Finding Sources
Searching PubMed
"chronic cough" AND treatment
Searching the Web
chronic cough sputum management guideline adults CHEST ERS
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
For chronic cough with sputum, Harrison emphasizes treating the underlying cause, not merely suppressing the cough. Productive cough helps clear airway secretions, so antitussives should generally be used cautiously.
Initial evaluation
- Chronic cough is cough lasting more than 8 weeks.
- Obtain a chest radiograph in virtually all cases.
- Examine expectorated sputum. If it is purulent, send bacterial culture and, when indicated, mycobacterial culture.
- Consider sputum cytology when malignancy, aspiration, or eosinophilic versus neutrophilic bronchitis is a concern.
- Hemoptysis needs prompt, separate assessment.
Harrison’s Principles of Internal Medicine, 22e, p. 316.
Cause-directed treatment
| Likely cause | Treatment approach in Harrison |
|---|---|
| Smoking-related chronic bronchitis/COPD | Smoking cessation and treatment of COPD with appropriate inhaled bronchodilators, with other therapy based on severity and exacerbations. |
| Bronchiectasis with infective exacerbation | Improve secretion clearance and bronchial hygiene. Give antibiotics directed by sputum culture or likely pathogens, commonly H. influenzae or Pseudomonas aeruginosa. Harrison states acute exacerbations are generally treated for at least 7-10 days, sometimes up to 14 days. |
| Upper-airway cough syndrome due to rhinitis/sinus disease | Therapy depends on cause and may include antihistamines, decongestants, nasal saline irrigation, intranasal glucocorticoid, antihistamine, or anticholinergic sprays. Antibiotics only if bacterial infection is suspected. |
| Asthma or cough-variant asthma | Inhaled glucocorticoid and intermittent inhaled beta-agonist bronchodilator. Confirm with spirometry/bronchodilator reversibility where possible. |
| Eosinophilic bronchitis | Inhaled glucocorticoid. Harrison describes sputum eosinophilia greater than 3% without airflow obstruction or bronchial hyperresponsiveness. |
| GERD-related cough | Dietary measures, elevating the head and torso during sleep, antacids, H2 blockers or proton-pump inhibitors, and measures to reduce reflux such as alginates where appropriate. |
| ACE-inhibitor cough | Stop the ACE inhibitor. An ARB is usually a suitable alternative. Improvement should generally be evident within about a month. |
| Tuberculosis or nontuberculous mycobacterial disease | Investigate with imaging and sputum testing, then provide organism-specific antimicrobial treatment rather than empirical cough suppression. |
Key point for a wet/productive cough
Persistent daily sputum, recurrent chest infections, crackles, or large-volume/purulent sputum should raise suspicion for bronchiectasis. Chest CT is the preferred test to confirm it. Management focuses on:
- Airway clearance and bronchial hygiene
- Sputum culture-guided antibiotics for exacerbations
- Identifying and treating the cause, such as aspiration, immune deficiency, obstruction, cystic fibrosis, or mycobacterial infection
Harrison’s description of bronchiectasis treatment is specifically aimed at controlling active infection and improving secretion clearance to lower airway microbial burden and reduce recurrent infections.
Antitussives
Harrison notes that cough suppressants are only modestly effective. Opioid agents such as codeine, hydrocodone, and morphine can suppress cough but cause sedation and other adverse effects. In a patient producing sputum, suppressing cough can impair airway clearance, so they are not the main treatment.
If chest X-ray, examination, spirometry, and initial cause-directed trials do not explain the cough, Harrison advises considering chest CT, because tumors, early interstitial lung disease, bronchiectasis, and atypical mycobacterial infection can be missed on plain radiography. Harrison’s Principles of Internal Medicine, 22e, p. 316.
A recent meta-analysis found PPIs may only slightly reduce cough severity, so reflux therapy should be targeted to patients with clinical evidence of reflux rather than assumed to help every chronic cough case, as summarized in this 2024 systematic review.
This is a shared conversation. Sign in to Orris to start your own chat.